Technical Analysis for DNTH - Dianthus Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 21.50 | 2.43% | 0.51 |
DNTH closed up 2.43 percent on Friday, April 26, 2024, on 43 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 13
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Slingshot Bearish | Bearish Swing Setup | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Doji - Bullish? | Reversal | 2.43% | |
| Multiple of Ten Bullish | Other | 2.43% | |
| Wide Bands | Range Expansion | 2.43% | |
| Lower Bollinger Band Touch | Weakness | 2.43% | |
| Oversold Stochastic | Weakness | 2.43% |
| Alert | Time |
|---|---|
| Possible NR7 | about 13 hours ago |
| Up 3% | about 14 hours ago |
| Rose Above Previous Day's High | about 15 hours ago |
| Up 2% | about 15 hours ago |
| 60 Minute Opening Range Breakout | about 16 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
Dianthus Therapeutics, Inc. operates as a clinical-stage biotechnology company that designs and delivers novel monoclonal antibodies. It develops monoclonal antibodies and complement therapeutics to deliver transformative medicines for patients with rare diseases. Dianthus Therapeutics, Inc. was incorporated in 2019 and is based in Waltham, Massachusetts, with an additional office in New York, New York
Keywords: Biotechnology Immunology Immune System Antibodies Rare Diseases Monoclonal Antibody Antibody
Classification
Keywords: Biotechnology Immunology Immune System Antibodies Rare Diseases Monoclonal Antibody Antibody
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 33.77 |
| 52 Week Low | 6.58 |
| Average Volume | 175,502 |
| 200-Day Moving Average | 16.08 |
| 50-Day Moving Average | 25.53 |
| 20-Day Moving Average | 24.19 |
| 10-Day Moving Average | 23.01 |
| Average True Range | 2.08 |
| RSI (14) | 37.50 |
| ADX | 20.52 |
| +DI | 15.20 |
| -DI | 26.45 |
| Chandelier Exit (Long, 3 ATRs) | 26.06 |
| Chandelier Exit (Short, 3 ATRs) | 25.96 |
| Upper Bollinger Bands | 28.14 |
| Lower Bollinger Band | 20.24 |
| Percent B (%b) | 0.16 |
| BandWidth | 32.66 |
| MACD Line | -1.17 |
| MACD Signal Line | -0.75 |
| MACD Histogram | -0.4172 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 23.17 | ||||
| Resistance 3 (R3) | 23.08 | 22.44 | 22.89 | ||
| Resistance 2 (R2) | 22.44 | 22.02 | 22.48 | 22.79 | |
| Resistance 1 (R1) | 21.97 | 21.75 | 22.21 | 22.06 | 22.70 |
| Pivot Point | 21.33 | 21.33 | 21.45 | 21.37 | 21.33 |
| Support 1 (S1) | 20.86 | 20.91 | 21.10 | 20.95 | 20.30 |
| Support 2 (S2) | 20.22 | 20.64 | 20.26 | 20.21 | |
| Support 3 (S3) | 19.75 | 20.22 | 20.11 | ||
| Support 4 (S4) | 19.84 |
